1/25/2024 0 Comments Advanced diagnostic laboratoryIt’s also a think tank, a fulcrum for new ideas - which is why its office area features entire walls of whiteboard to help capture ideas and cultivate discussion. Flexibility fuels innovationĭesigned as a “flexible” space, the ADL moves beyond a traditional lab model: it can be quickly modified to meet each project’s needs. “I think a lot of these companies have really cool projects, but we have to push the boundaries, we have to know where they fail, and we have to know where they work so that we can implement them for our patients,” he says. The collaboration is part of Mayo Clinic’s movement towards “precision medicine” and is aimed at advancing such diagnostics in a clinically relevant, globally accessible manner.īenjamin Kipp, Ph.D., is director of the ADL. So we recently executed an updated agreement with Thermo Fisher to focus on innovation and develop novel tests on three of their technology platforms - next-generation sequencing (NGS), mass spectrometry, and allergy and autoimmunity diagnostic tools.” “The challenges of the COVID pandemic really strengthened our relationship. “Thermo Fisher is a very innovative, large diagnostic company that DLMP has worked with for a number of years,” says Bates. These resources allow us to strike more business agreements and co-development relationships, move quickly, and bring more capabilities to the collaboration.”Ĭo-development agreements have already been struck with, for example, Numares, a German-based company that is leveraging nuclear magnetic resonance (NMR) technology, using AI to quantify “metabolite constellations” and, thus, help patients with undiagnosed diseases or conditions Breath Diagnostics, a medical device company in Kentucky that is developing a test to detect lung cancer using patients’ exhaled breath and more recently, Thermo Fisher Scientific. “This space has room and resources for evaluating technology quickly, enabling us early access to technology and the opportunity to test it, with the potential to influence the final product. “New disruptive technologies and industry collaborations are keys to our success in innovation,” says Kathy Bates, senior director of Laboratory Services and Partnership Development in DLMP and administrator of the ADL. Located on the third floor of One Discovery Square in a 9,600-square-foot space, the lab was born out of an initiative between Mayo’s Department of Laboratory Medicine and Pathology (DLMP) and the Center for Individualized Medicine (CIM). The ADL’s mission is to foster innovation - including grassroots innovation - across different specialties, through partnerships in-house as well as with external companies. The Advanced Diagnostics Laboratory (ADL) is a visionary space designed to continue Mayo Clinic’s long tradition of pioneering patient treatments and diagnostics.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |